Home › Non-Small Cell Lung Cancer › California › Glendale
Non-Small Cell Lung Cancer clinical trials in Glendale, CA
9 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Glendale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
RecruitingPhase 2/3
- Los Angeles Cancer Network, Glendale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Oncura Health - Corporate (Central IDS & Regulatory Only), Glendale
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- Los Angeles Cancer Network, Glendale
- Glendale Adventist Medical Center, Glendale
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
- OPN Healthcare, Inc, Glendale
Pan-tumor MRD Study
RecruitingObservational study
- Los Angeles Cancer Network (LACN), Glendale
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
RecruitingPhase 3
- Oncura Health d.b.a.Los Angeles Cancer Network, Glendale
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
RecruitingPhase 3
- OPN Healthcare, Inc., Glendale
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Los Angeles Cancer Network, Glendale
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 2
- OPN Healthcare, Inc., Glendale
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Glendale
- Major Depressive Disorder12 studies
- Depression6 studies
- Cancer (all types)5 studies
- Obesity5 studies
- Breast Cancer4 studies
- Colorectal Cancer4 studies
- Lung Cancer4 studies
- Metastatic Cancer3 studies
- Coronary Artery Disease3 studies
- Melanoma3 studies
- Macular Edema3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.